X-22 is an innovative smoking cessation aid in development with an active IND with the FDA.

frontpage-image

Heracles Pharmaceuticals, LLC is a wholly-owned subsidiary of 22nd Century Group, Inc. (NYSE MKT: XXII),
a plant biotechnology company dedicated to reducing the harm caused by smoking.